Marchex Inc

Marchex operates with a market cap of $76.63 million and a price-to-book ratio of 2.55, indicating a premium valuation relative to its book value. The company holds $5.27 million in cash and equivalents, while its total liabilities amount to $9.60 million, resulting in a low debt-to-equity ratio of 0.01 and a current ratio of 2.36, suggesting strong short-term liquidity [doc:HA-latest]. Profitability metrics reveal a challenging operating environment. The company reported a net loss of $5.24 million and an operating loss of $5.72 million, translating to a negative return on equity of -17.4% and a return on assets of -13.19%. These figures fall significantly below the industry median for profitability, indicating underperformance relative to peers [doc:HA-latest]. Geographically and segment-wise, Marchex's revenue concentration is not explicitly disclosed in the input data. However, the company's product offerings are primarily software-based, with a focus on AI-driven marketing and communication tools. This suggests a broad customer base across industries, though the lack of segment-specific revenue data limits a deeper analysis of geographic or product concentration [doc:HA-latest]. Looking ahead, Marchex is projected to maintain a negative operating income trajectory, with no significant revenue growth expected in the next fiscal year. The company's free cash flow remains negative at -$4.04 million, and capital expenditures of -$1.48 million indicate ongoing investment in infrastructure or technology. These trends suggest a continued focus on growth over immediate profitability [doc:HA-latest]. Risk factors include the company's negative net income and operating cash flow, which could pressure liquidity if cash burn accelerates. However, the low dilution risk and absence of immediate filing-based flags suggest that equity issuance is not currently a pressing concern. The company's low debt load also reduces credit risk [doc:HA-latest]. Recent events include the publication of the latest financial snapshot, which shows continued losses and a lack of positive cash flow. Analysts have assigned a mean price target of $4.00, with a "Buy" recommendation from one analyst and no "Strong Buy" ratings. This suggests cautious optimism but limited consensus on near-term upside [doc:HA-latest].